We studied the induction, severity, and rate of progression of inflammatory bowel disease (IBD) induced in SCID mice by the adoptive transfer of low numbers of the following purified BALB/c CD4(+) T cell subsets: 1) unfractionated, peripheral, small (resting), or large (activated) CD4(+) T cells; 2) fractionated, peripheral, small, or large, CD45RB(high) or CD45RB(low) CD4(+) T cells; and 3) peripheral IL-12-unresponsive CD4(+) T cells from STAT-4-deficient mice, The adoptive transfer into SCID host of comparable numbers of CD4(+) T cells was used to assess the colitis-inducing potency of these subsets, Small CD45RB(high) CD4(+) T lymphocytes and activated CD4(+) T blasts induced early (6-12 wk posttransfer) and severe disease, while small resting and unfractionated CD4(+) T cells or CD45RB(low) T lymphocytes induced a late-onset disease 12-16 wk posttransfer, SCID mice transplanted with STAT-4(-/-) CD4(+) T cells showed a tate-onset IBD manifest >20 wk posttransfer, In SCID mice with IBD transplanted with IL-12-responsive CD4(+) T cells, the colonic lamina propria CD4(+) T cells showed a mucosa-seeking memory/ effector CD45RB(low) Th1 phenotype abundantly producing IFN-gamma and TNF-alpha. In SCID mice transplanted with IL-12-unresponsive STAT-4(-/-) CD4(+) T cells, the colonic lamina propria, mesenteric lymph node, and splenic CD4(+) T cells produced very little IFN-gamma but abundant levels of TNF-alpha. The histopathologic appearance of colitis in all transplanted SCID mice was similar, These data indicate that CD45RB(high) and CD45RB(low), IL-12-responsive and IL-12-unresponsive CD4(+) T lymphocytes and lymphoblasts have IBD-inducing potential though of varying potency.